Soni Aashish, Siemann Maria, Grabos Martha, Murmann Tamara, Pantelias Gabriel E, Iliakis George
Institute of Medical Radiation Biology, University of Duisburg-Essen Medical School, 45122 Essen, Germany.
Institute of Nuclear Technology and Radiation Protection, National Centre for Scientific Research ''Demokritos,'' Aghia Paraskevi Attikis, 15310 Athens, Greece.
Nucleic Acids Res. 2014 Jun;42(10):6380-92. doi: 10.1093/nar/gku298. Epub 2014 Apr 19.
In mammalian cells, ionizing radiation (IR)-induced DNA double-strand breaks (DSBs) are repaired in all phases of the cell cycle predominantly by classical, DNA-PK-dependent nonhomologous end joining (D-NHEJ). Homologous recombination repair (HRR) is functional during the S- and G2-phases, when a sister chromatid becomes available. An error-prone, alternative form of end joining, operating as backup (B-NHEJ) functions robustly throughout the cell cycle and particularly in the G2-phase and is thought to backup predominantly D-NHEJ. Parp-1, DNA-ligases 1 (Lig1) and 3 (Lig3), and Xrcc1 are implicated in B-NHEJ. Chromosome and chromatid translocations are manifestations of erroneous DSB repair and are crucial culprits in malignant transformation and IR-induced cell lethality. We analyzed shifts in translocation formation deriving from defects in D-NHEJ or HRR in cells irradiated in the G2-phase and identify B-NHEJ as the main DSB repair pathway backing up both of these defects at the cost of a large increase in translocation formation. Our results identify Parp-1 and Lig1 and 3 as factors involved in translocation formation and show that Xrcc1 reinforces the function of Lig3 in the process without being required for it. Finally, we demonstrate intriguing connections between B-NHEJ and DNA end resection in translocation formation and show that, as for D-NHEJ and HRR, the function of B-NHEJ facilitates the recovery from the G2-checkpoint. These observations advance our understanding of chromosome aberration formation and have implications for the mechanism of action of Parp inhibitors.
Mutat Res Genet Toxicol Environ Mutagen. 2015-11
Mutat Res Genet Toxicol Environ Mutagen. 2021-7
Nucleic Acids Res. 2006
DNA Repair (Amst). 2008-2-1
Nucleic Acids Res. 2025-6-20
J Transl Int Med. 2022-3-5
Int J Mol Sci. 2022-11-1
Cancers (Basel). 2021-12-20
Nat Med. 2013-10-7
Science. 2013-8-9
Nat Rev Cancer. 2013-6-13
Blood. 2013-4-8